Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

United Therapeutics Stock (NASDAQ:UTHR), Quotes and News Summary

Q: What sector and industry does United Therapeutics (UTHR) operate in?

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

United Therapeutics Stock (NASDAQ: UTHR) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 443.772K
Day Range	- - -
52 Wk Range	204.440 - 261.540
Market Cap	$11.073B
P/E Ratio	11.878
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	11.77%
Days to Cover	8.73

Recent News

United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings

Legal battle unfolds as United Therapeutics challenges FDA's handling of Liquidia's drug approval process. Explore the implications on PH-ILD, potential 30-month stay, and recent financial performance.

Vandana Singh

This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate

United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:

Priya Nigam

Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About United Therapeutics Corp

Sector

Health Care

Industry

Biotechnology

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy United Therapeutics (UTHR) stock?

You can purchase shares of United Therapeutics (NASDAQ: UTHR) through any online brokerage.

View our list of the best stock brokerages.

Who are United Therapeutics's (UTHR) competitors?

Other companies in United Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for United Therapeutics (UTHR) stock?

The latest price target for United Therapeutics (NASDAQ: UTHR) was reported by Wells Fargo on Thursday, March 7, 2024. The analyst firm set a price target for 325.00 expecting UTHR to rise to within 12 months (a possible 38.12% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for United Therapeutics (UTHR)?

The stock price for United Therapeutics (NASDAQ: UTHR) is $235.31 last updated April 17, 2024 at 4:00 PM EDT.

Does United Therapeutics (UTHR) pay a dividend?

There are no upcoming dividends for United Therapeutics.

When is United Therapeutics (NASDAQ:UTHR) reporting earnings?

United Therapeutics’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Is United Therapeutics (UTHR) going to split?

There is no upcoming split for United Therapeutics.

What sector and industry does United Therapeutics (UTHR) operate in?

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-